![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ST6GALNAC6 mRNA] | CTD | PMID:31150632 | (1->4)-beta-D-glucan | multiple interactions | ISO | RGD:1622348 | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ST6GALNAC6 mRNA | CTD | PMID:36331819 | 1,2-dichloroethane | decreases expression | ISO | RGD:1622348 | 6480464 | ethylene dichloride results in decreased expression of ST6GALNAC6 mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | affects expression | ISO | RGD:1622348 | 6480464 | 1, 2-Dimethylhydrazine affects the expression of ST6GALNAC6 mRNA | CTD | PMID:22206623 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | RGD:1622348 | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | RGD:1622348 | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1622348 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ST6GALNAC6 mRNA | CTD | PMID:26290441, PMID:28213091 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ST6GALNAC6 mRNA | CTD | PMID:33387578 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1622348 | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ST6GALNAC6 gene] | CTD | PMID:28213091 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1622348 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ST6GALNAC6 mRNA | CTD | PMID:21570461, PMID:26377647 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1354318 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ST6GALNAC6 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ST6GALNAC6 mRNA | CTD | PMID:28628672 | 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:1622348 | 6480464 | 4, 4'-diaminodiphenylmethane results in increased expression of ST6GALNAC6 mRNA | CTD | PMID:18648102 | 4,4'-sulfonyldiphenol | increases methylation | ISO | RGD:1622348 | 6480464 | bis(4-hydroxyphenyl)sulfone results in increased methylation of ST6GALNAC6 exon | CTD | PMID:33297965 | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ST6GALNAC6 mRNA | CTD | PMID:36041667 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of ST6GALNAC6 mRNA | CTD | PMID:28959563 | aflatoxin B1 | increases expression | ISO | RGD:1622348 | 6480464 | Aflatoxin B1 results in increased expression of ST6GALNAC6 mRNA | CTD | PMID:19770486 | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of ST6GALNAC6 mRNA | CTD | PMID:33354967 | benzo[a]pyrene | increases expression | ISO | RGD:1622348 | 6480464 | Benzo(a)pyrene results in increased expression of ST6GALNAC6 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | increases methylation | ISO | RGD:1354318 | 6480464 | Benzo(a)pyrene results in increased methylation of ST6GALNAC6 promoter | CTD | PMID:27901495 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of ST6GALNAC6 mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ST6GALNAC6 mRNA | CTD | PMID:36041667 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ST6GALNAC6 mRNA | CTD | PMID:34947998 | bisphenol A | multiple interactions | ISO | RGD:1354318 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ST6GALNAC6 mRNA | CTD | PMID:28628672 | bisphenol F | multiple interactions | ISO | RGD:1354318 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ST6GALNAC6 mRNA | CTD | PMID:28628672 | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ST6GALNAC6 mRNA | CTD | PMID:36041667 | cisplatin | decreases expression | ISO | RGD:1354318 | 6480464 | Cisplatin results in decreased expression of ST6GALNAC6 mRNA | CTD | PMID:27392435 | copper(II) sulfate | decreases expression | ISO | RGD:1354318 | 6480464 | Copper Sulfate results in decreased expression of ST6GALNAC6 mRNA | CTD | PMID:19549813 | cytarabine | decreases expression | ISO | RGD:1354318 | 6480464 | Cytarabine results in decreased expression of ST6GALNAC6 mRNA | CTD | PMID:21198554 | dexamethasone | multiple interactions | ISO | RGD:1354318 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ST6GALNAC6 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ST6GALNAC6 mRNA | CTD | PMID:28628672 | doxorubicin | decreases expression | ISO | RGD:1354318 | 6480464 | Doxorubicin results in decreased expression of ST6GALNAC6 mRNA | CTD | PMID:29803840 | ethanol | affects splicing | ISO | RGD:1622348 | 6480464 | Ethanol affects the splicing of ST6GALNAC6 mRNA | CTD | PMID:30319688 | fenvalerate | increases expression | EXP | | 6480464 | fenvalerate results in increased expression of ST6GALNAC6 mRNA | CTD | PMID:30307764 | folic acid | increases expression | ISO | RGD:1622348 | 6480464 | Folic Acid results in increased expression of ST6GALNAC6 mRNA | CTD | PMID:25629700 | gallic acid | increases expression | ISO | RGD:1354318 | 6480464 | Gallic Acid results in increased expression of ST6GALNAC6 mRNA | CTD | PMID:34408198 | indometacin | multiple interactions | ISO | RGD:1354318 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ST6GALNAC6 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of ST6GALNAC6 mRNA | CTD | PMID:28628672 | methotrexate | affects expression | ISO | RGD:1622348 | 6480464 | Methotrexate affects the expression of ST6GALNAC6 mRNA | CTD | PMID:18502557 | N-nitrosodiethylamine | multiple interactions | ISO | RGD:1622348 | 6480464 | [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of ST6GALNAC6 gene | CTD | PMID:23968726 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of ST6GALNAC6 mRNA | CTD | PMID:33387578 | PCB138 | multiple interactions | ISO | RGD:1622348 | 6480464 | [2 more ... | CTD | PMID:25510870 | perfluorononanoic acid | decreases expression | ISO | RGD:1354318 | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of ST6GALNAC6 mRNA | CTD | PMID:32588087 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | RGD:1622348 | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ST6GALNAC6 mRNA | CTD | PMID:36331819 | phenobarbital | multiple interactions | ISO | RGD:1622348 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of ST6GALNAC6 mRNA] | CTD | PMID:19482888 | phenobarbital | decreases expression | ISO | RGD:1622348 | 6480464 | Phenobarbital results in decreased expression of ST6GALNAC6 mRNA | CTD | PMID:19482888 | piperonyl butoxide | multiple interactions | ISO | RGD:1622348 | 6480464 | [Piperonyl Butoxide co-treated with Diethylnitrosamine] affects the methylation of ST6GALNAC6 gene | CTD | PMID:23968726 | propiconazole | decreases expression | ISO | RGD:1622348 | 6480464 | propiconazole results in decreased expression of ST6GALNAC6 mRNA | CTD | PMID:21278054 | sunitinib | decreases expression | ISO | RGD:1354318 | 6480464 | Sunitinib results in decreased expression of ST6GALNAC6 mRNA | CTD | PMID:31533062 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of ST6GALNAC6 mRNA | CTD | PMID:31150632 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ST6GALNAC6 mRNA] | CTD | PMID:31150632 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of ST6GALNAC6 mRNA | CTD | PMID:34492290 | toluene | decreases expression | EXP | | 6480464 | Toluene results in decreased expression of ST6GALNAC6 mRNA | CTD | PMID:22967744 | trichloroethene | decreases expression | EXP | | 6480464 | Trichloroethylene results in decreased expression of ST6GALNAC6 mRNA | CTD | PMID:33387578 | triptonide | affects expression | ISO | RGD:1622348 | 6480464 | triptonide affects the expression of ST6GALNAC6 mRNA | CTD | PMID:33045310 | |